Erkan Doğan

401 total citations
40 papers, 244 citations indexed

About

Erkan Doğan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Erkan Doğan has authored 40 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Erkan Doğan's work include Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (4 papers) and Breast Cancer Treatment Studies (4 papers). Erkan Doğan is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (4 papers) and Breast Cancer Treatment Studies (4 papers). Erkan Doğan collaborates with scholars based in Türkiye, United States and Kazakhstan. Erkan Doğan's co-authors include Eylem Sevinç, Nilgün Çaylan, Melahat Melek Oğuz, Gülbin Gökçay, Kadri Altundağ, Nedim Turan, Aydemir Ölmez, İbrahim Petekkaya, Şuayib Yalçın and Yavuz Özışık and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Oral and Maxillofacial Surgery.

In The Last Decade

Erkan Doğan

34 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erkan Doğan Türkiye 10 56 52 46 36 32 40 244
Zongwen Shuai China 13 40 0.7× 38 0.7× 30 0.7× 21 0.6× 10 0.3× 38 410
Wen Dong China 8 55 1.0× 49 0.9× 54 1.2× 20 0.6× 16 0.5× 21 308
Qingnan He China 9 74 1.3× 13 0.3× 45 1.0× 21 0.6× 14 0.4× 22 302
Lucía Méndez-Sánchez Mexico 9 33 0.6× 52 1.0× 9 0.2× 9 0.3× 9 0.3× 23 379
Maria Marta Sarquis Soares Brazil 11 61 1.1× 27 0.5× 8 0.2× 15 0.4× 54 1.7× 23 383
Marie Øbro Fosbøl Denmark 9 25 0.4× 53 1.0× 75 1.6× 10 0.3× 31 1.0× 20 344
Chengquan Ma China 8 12 0.2× 39 0.8× 49 1.1× 38 1.1× 33 1.0× 29 260
Yen‐Chun Liu Taiwan 10 116 2.1× 46 0.9× 14 0.3× 3 0.1× 37 1.2× 25 311
Amit Gulati United States 8 22 0.4× 20 0.4× 30 0.7× 5 0.1× 6 0.2× 37 189
Maria J. Henwood United States 10 36 0.6× 16 0.3× 28 0.6× 21 0.6× 9 0.3× 12 348

Countries citing papers authored by Erkan Doğan

Since Specialization
Citations

This map shows the geographic impact of Erkan Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkan Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkan Doğan more than expected).

Fields of papers citing papers by Erkan Doğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkan Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkan Doğan. The network helps show where Erkan Doğan may publish in the future.

Co-authorship network of co-authors of Erkan Doğan

This figure shows the co-authorship network connecting the top 25 collaborators of Erkan Doğan. A scholar is included among the top collaborators of Erkan Doğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkan Doğan. Erkan Doğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doğan, Erkan, et al.. (2024). Clinical and Laboratory Effects of Foodborne Illness in Children. Foodborne Pathogens and Disease. 21(6). 366–369. 2 indexed citations
2.
Doğan, Erkan, et al.. (2024). Unveiling the Nexus: Is Iron and Sodium Deficiency in Children with Febrile Seizures Risk Factor?. DergiPark (Istanbul University). 6(3). 491–495.
3.
Doğan, Erkan, Eylem Sevinç, Ahmet Musmul, et al.. (2021). Blood and Stool Arsenic Levels Are Decisive for Diagnosing Children’s Functional Gastrointestinal Disease (FGD). Biological Trace Element Research. 200(7). 3050–3059. 3 indexed citations
4.
Doğan, Erkan, et al.. (2021). Evaluation of Gentamicin Ototoxicity in Newborn Infants: A Retrospective Observational Study. International journal of pediatrics. 9(3). 13137–13144. 1 indexed citations
5.
Sevinç, Eylem, et al.. (2021). Niveles séricos y fecales de plomo en niños con distintos trastornos digestivos funcionales. Anales de Pediatría. 96(1). 35–42. 1 indexed citations
6.
Doğan, Erkan, et al.. (2021). Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis. Clinical and Experimental Hepatology. 7(3). 278–285. 4 indexed citations
7.
Sevinç, Eylem, et al.. (2021). Blood and faecal lead levels in children with various functional gastrointestinal disorders. SHILAP Revista de lepidopterología. 96(1). 35–42. 2 indexed citations
8.
Sevinç, Eylem, et al.. (2018). Progressive familial intrahepatic cholestasis in children. 1(1).
9.
Doğan, Erkan, et al.. (2018). SLC26A3 mutation in Turkish neonate and her sibling with congenital chloride diarrhea. Türk Pediatri Arşivi. 55(1). 76–78. 3 indexed citations
10.
Doğan, Erkan, et al.. (2018). Assessment of balance skills and falling risk in children with congenital bilateral profound sensorineural hearing loss. International Journal of Pediatric Otorhinolaryngology. 116. 75–78. 14 indexed citations
11.
Doğan, Erkan, Erhan Dursun, Emre Tosun, et al.. (2017). Evaluation of hyaluronic matrix efficacy in sinus augmentation: a randomized-controlled histomorphometric and micro–computed tomography analysis. International Journal of Oral and Maxillofacial Surgery. 46(7). 931–937. 20 indexed citations
12.
Payandeh, Mehrdad, et al.. (2015). Efficacy of Rapamycin Therapy in the Women with Metastatic Breast Cancer in West Iran. Journal of Cancer Prevention. 3(3). 51–53. 1 indexed citations
13.
Can, Alper, Erkan Doğan, İbrahim Vedat Bayoğlu, et al.. (2014). Multicenter Epidemiologic Study on Hepatocellular Carcinoma in Turkey. Asian Pacific Journal of Cancer Prevention. 15(6). 2923–2927. 20 indexed citations
14.
Esen, Ramazan, et al.. (2013). Plasma Concentrations of Some Trace Element and Heavy Metals in Patients with Metastatic Colon Cancer. Van Yüzüncü Yıl University Academic Data Management System. 1 indexed citations
15.
Turan, Nedim, Faysal Dane, Olçun Ümit Ünal, et al.. (2013). Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.. Journal of Clinical Oncology. 31(15_suppl). e14533–e14533. 1 indexed citations
16.
Doğan, Erkan, et al.. (2012). Pure mucinous carcinoma of the breast: a single center experience.. PubMed. 16(3). 565–7. 2 indexed citations
17.
Doğan, Erkan, Hikmet Yorgun, İbrahim Petekkaya, et al.. (2012). Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. Medical Oncology. 29(5). 3232–3239. 12 indexed citations
18.
Aksoy, Sercan, Ömer Dızdar, Didem Şener Dede, et al.. (2010). Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Medical Oncology. 28(S1). 75–79. 10 indexed citations
19.
Aksoy, Sercan, Didem Şener Dede, Erkan Doğan, et al.. (2010). Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis.. Journal of Clinical Oncology. 28(15_suppl). e13664–e13664. 1 indexed citations
20.
Doğan, Erkan, et al.. (2003). Nodular regenerative hyperplasia of the liver: a case report.. PubMed. 14(1). 64–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026